Completed NA INTERVENTIONAL 2-arm NCT04456829

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors (Resveratrol)

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin

Sponsor: TCI Co., Ltd.

Conditions Proinflammatory Cytokines Skin Conditions

Interventions Placebo drink Resveratrol drink

Updated 6 times since 2020 Last updated: Jan 13, 2021 Started: Sep 17, 2020 Primary completion: Nov 10, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04456829, this NA trial focuses on Proinflammatory Cytokines and Skin Conditions and remains completed. Sponsored by TCI Co., Ltd., it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Dec 2025 — Present [monthly]

Completed NA
Sep 2024 — Dec 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2021 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting NA

Status: Not Yet Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Aug 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TCI Co., Ltd.

Data source: TCI Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tainan, Taiwan